The emergence of pathophysiological, epidemiologic, and genetic data strongly supports
the causality for lipoprotein (a)[Lp (a)] in cardiovascular disease (CVD) and calcific aortic …

Heterozygous familial hypercholesterolemia (HeFH) is a genetic disorder that elevates low-
density lipoprotein cholesterol and increases the risk of premature atherosclerotic …

Aims A thorough characterization of the relationship between elevated lipoprotein (a)[Lp (a)]
and coronary artery disease (CAD) is lacking. This study aimed to quantitatively assess the …

Abstract Background High lipoprotein (a)[Lp (a)] levels are an independent factor for worse
prognosis in patients with coronary artery disease (CAD). However, the association between …

A vegetarian diet has been associated with a lower risk of coronary artery disease (CAD).
Plasma triacylglycerols, ceramides, and phosphatidylcholines may improve prediction of …

Background Lipoprotein (a)(Lp (a)) is a well-recognized independent risk factor for
atherosclerotic cardiovascular disease (ASCVD). However, limited data are available on the …

On cholesterol scales, lipoprotein (a) and LDL appeared equal as causal factors for
myocardial infarction; however, lipoprotein (a) was most important for mortality. Lipoprotein …

There is now significant evidence to support an independent causal role for lipoprotein
(a)(Lp (a)) as a risk factor for atherosclerotic cardiovascular disease. Plasma Lp (a) …

Background Although current evidence suggests a causal association between lipoprotein
(a)[Lp (a)] and cardiovascular disease, there is still no consensus on its association with …

Purpose The LipidCardio Study was established for in-depth analyses of cardiovascular risk
factors, providing well-defined cardiovascular and metabolic phenotypes. In particular, the …